Meanwhile, in stage III and IV of HCC, high expression of ABCG2 (OS P = 0.02), ALDH1A1 (OS P = 0.042), EpCAM (P = 0.038), CD133 (PFS P = 0.045), CD13 (PFS P = 0.042) CD44 (PFS P = 0.031), and CD47 (PFS P = 0.011) had positive correlation with good prognosis, respectively, while CD24 (OS HR P = 0.011), SOX9 (OS P = 0.0025) and SOX12 (OS P = 0.0005, PFS P = 0.0077) had negative correlation (Supplementary Figure 5). This evidence concerns the gene CD47 and hepatocellular carcinoma.